SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-18-002780
Filing Date
2018-03-09
Accepted
2018-03-09 16:30:18
Documents
2
Period of Report
2018-03-12
Effectiveness Date
2018-03-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0318_delmarpharma.htm DEF 14A 622942
2 GRAPHIC img_001.jpg GRAPHIC 93185
  Complete submission text file 0001213900-18-002780.txt   752572
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-37823 | Film No.: 18680466
SIC: 2834 Pharmaceutical Preparations